Pay in 4 interest-free payments of $6.67 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
doi: 10.3389/fendo.2024.1431292 Received 11 May 2024 Accepted 08 July 2024 Published 24 July 2024 Volume 15 - 2024 Edited by Hisamitsu Ishihara, Nihon University, Japan Reviewed by Alessandro Pocai, Janssen Research and Development, United States Hiroshi Nomoto, Hokkaido University Hospital, Japan Updates Copyright 2024 Liu
As with any medication, patients may experience: Mild to Moderate Nausea: Although it causes less nausea than other GLP-1 receptor agonists, some patients may still experience this symptom, especially when starting treatment
Symptoms vary depending on the size and location of the bezoar
Provider comparison table The no-membership model works in Pomegranate Health favor for patients who want flexibility
US$ 21.91
US$ 21.70
US$ 29.77
US$ 24.88
